Article
Current State and Future Prospects of Direct-to-Consumer Pharmacogenetics
1 Jan 2012
Abstract excerpt
Direct-to-consumer (DTC) DNA testing has grown from contentious beginnings into a global industry, by providing a wide range of personal genomic information directly to its clients. These companies, typified by the well-established 23andMe, generally carry out a gene-chip analysis of single-nucleotide polymorphisms (SNPs) using DNA extracted from a saliva sample. These genetic data are then assimilated and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
